[Our preliminary observations of plasma endothelin behavior in type II diabetes mellitus].
Several studies have lately been made to explain the pathophysiologic role of endothelin, a vasoconstrictive peptide, in some clinical syndromes. Within a larger plan of the probable role of this molecule in development of diabetic vasculopathy, we have preliminarily investigated the plasma endothelin-1 level in type II diabetic patients. 24 type II diabetic patients and 10 healthy control subjects comparable for sex and age were examined. Plasmatic ET-1 was determined by radioimmunoassay (Amersham, UK). The mean +/- SD was respectively 11.4 +/- 2.9 pg/ml in diabetic patients and 8.2 +/- 3.9 pg/ml in the control group. Statistical analysis showed a significant difference between two groups. These results suggest an involvement of endothelin in the vascular complications of diabetes. Nevertheless, to better explain the question, we think further and larger studies are required.